BRCA1 and ovarian cancer: Recently, downregulation of m6A erasers FTO and ALKBH5 has been found to facilitate PARPi resistance by increasing m6A modification in FZD10 mRNA to promote Wnt signaling in BRCA1/2-mutated ovarian cancer cells [24].